3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
9
Neoplasms
6
Prostatic Neoplasms
5
Colorectal Neoplasms
4
Uterine Cervical Neoplasms
3
Lung Neoplasms
3
Thyroid Neoplasms
2
Lymphoma
2
Communication
2
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sexual Dysfunction, Physiological
1
Rectal Neoplasms
1
Patient Preference
1
Papillomavirus Infections
1
Papillary Thyroid Microcarcinoma
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Motor Activity
1
Melanoma
1
Leukemia
1
Hematologic Neoplasms
1
Health Behavior
1
HIV Infections
1
Coitus
1
Carcinoma, Transitional Cell
1
Cancer Prevention
1
Interventions
Surveys and Questionnaires
9
Cystectomy
6
Blood Specimen Collection
5
Neoadjuvant Therapy
4
Cystoscopy
4
Drug Therapy
3
avelumab
2
Urination
2
Urinary Diversion
2
Surgical Procedures, Operative
2
Radiotherapy
2
Pioglitazone
2
Microarray Analysis
2
Methods
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Immunohistochemistry
2
Defecation
2
Biopsy
2
5-aminolevulinic acid hexyl ester
2
trastuzumab deruxtecan
1
sargramostim
1
pembrolizumab
1
erdafitinib
1
enfortumab vedotin
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Watchful Waiting
1
Urinary Sediment Analysis
1
Therapeutics
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Urinary Bladder Neoplasms
×
Focus Groups
×
Clear all
NCT07091565
2025-08-03
SPARC
King's College London
Enrolling by invitation
60 enrolled